An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

CNBC host Jim Cramer continues to pound the table on Eli Lilly’s (LLY) stock. The host of the TV show “Mad Money” continues to be a cheerleader for LLY stock, saying repeatedly that the pharmaceutical ...

Over the last nine months, four senators led by Sen. Dick Durbin (D-Ill.) have conducted an inquiry into the growing partnerships between direct-to-consumer telehealth companies and pharmaceutical ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

The American Academy of Dermatology has updated its guidelines for treating and managing atopic dermatitis with topical and ...

President Donald Trump says that he was likely to impose tariffs on pharmaceuticals as soon as the end of this month.

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...